王楠, 许彭鹏, 王黎, 程澍, 赵维莅, & 孙慧平. (2019). 利妥昔单抗联合化疗治疗229例滤泡性淋巴瘤患者的预后研究. 中华血液学杂志, 40(1), 46-51. https://doi.org/10.3760/cma.j.issn.0253-2727.2019.01.009
Chicago Style (17th ed.) Citation王楠, 许彭鹏, 王黎, 程澍, 赵维莅, and 孙慧平. "利妥昔单抗联合化疗治疗229例滤泡性淋巴瘤患者的预后研究." 中华血液学杂志 40, no. 1 (2019): 46-51. https://doi.org/10.3760/cma.j.issn.0253-2727.2019.01.009.
MLA (9th ed.) Citation王楠, et al. "利妥昔单抗联合化疗治疗229例滤泡性淋巴瘤患者的预后研究." 中华血液学杂志, vol. 40, no. 1, 2019, pp. 46-51, https://doi.org/10.3760/cma.j.issn.0253-2727.2019.01.009.
Warning: These citations may not always be 100% accurate.